EIKONIZO THERAPEUTICS
LIVE

Serial Number

90747075

Owner

Eikonizo Therapeutics, Inc.

Attorney

Christina M. Licursi

Filing Date

Jun 1, 2021

Add to watchlist:

No watchlists yet
View on USPTO

EIKONIZO THERAPEUTICS Trademark

Serial Number: 90747075

EIKONIZO THERAPEUTICS is a trademark filed by Eikonizo Therapeutics, Inc. on June 1, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Eikonizo Therapeutics, Inc. (2 trademarks)

c/o Lab Central
Cambridge, MA 02139

Entity Type: 03

Trademark Details

Filing Date

June 1, 2021

Registration Date

Not Registered

Published for Opposition

May 14, 2024

Goods & Services

Pharmaceutical, therapeutic and biopharmaceutical agents for the treatment of neurodegenerative and neurological diseases, namely, amyotrophic lateral sclerosis (ALS), Alzheimer's Disease (AD), and chemotherapy-induced peripheral neuropathy (CIPN), treatments in oncology, namely, chemotherapy-induced peripheral neuropathy (CIPN), treatments in nephrology, namely, autosomal dominant polycyclic kidney disease (ADPKD), and treatments in cardiology, namely, cardiac diseases; pharmaceutical, therapeutic and biopharmaceutical preparations and substances or the treatment of neurodegenerative and neurological diseases, namely, amyotrophic lateral sclerosis (ALS), Alzheimer's Disease (AD), and chemotherapy-induced peripheral neuropathy (CIPN), treatments in oncology, namely, chemotherapy-induced peripheral neuropathy (CIPN), treatments in nephrology, namely, autosomal dominant polycyclic kidney disease (ADPKD), and treatments in cardiology, namely, cardiac diseases; diagnostic agents, preparations, substances and diagnostic materials in the form of preparations for medical purposes; imaging agents for positron emission tomography (PET) imaging for delivery of materials to target sites within the body for diagnostic purposes; imaging agents for positron emission tomography (PET) imaging for use in detecting disease, namely, radio tracers for positron emission tomography (PET) imaging

Filing History

STATEMENT OF USE PROCESSING COMPLETE
Jan 10, 2026 SUPC
USE AMENDMENT FILED
Jan 9, 2026 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 9, 2026 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 14, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jul 14, 2025 EX2G
SOU TEAS EXTENSION RECEIVED
Jul 9, 2025 EEXT
SOU EXTENSION 2 FILED
Jul 8, 2025 EXT2
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 25, 2025 EXRA
SOU EXTENSION 1 GRANTED
Apr 24, 2025 EX1G
DIVISIONAL PROCESSING COMPLETE
Apr 24, 2025 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 17, 2025 AITU
SOU EXTENSION 1 FILED
Jan 9, 2025 EXT1
DIVISIONAL REQUEST RECEIVED
Jan 9, 2025 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Jan 9, 2025 ERTD
SOU TEAS EXTENSION RECEIVED
Jan 9, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 9, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 14, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 14, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 24, 2024 NONP
EXPARTE APPEAL TERMINATED
Apr 11, 2024 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 10, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 27, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 27, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 26, 2023 ERFR
EX PARTE APPEAL-INSTITUTED
Apr 26, 2023 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Apr 26, 2023 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Apr 26, 2023 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 26, 2022 GNFN
FINAL REFUSAL E-MAILED
Oct 26, 2022 GNFR
FINAL REFUSAL WRITTEN
Oct 26, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 6, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 6, 2022 CRFA
ASSIGNED TO LIE
Oct 5, 2022 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 25, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 25, 2022 GNRN
NON-FINAL ACTION E-MAILED
Feb 25, 2022 GNRT
NON-FINAL ACTION WRITTEN
Feb 25, 2022 CNRT
ASSIGNED TO EXAMINER
Feb 15, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 25, 2021 NWOS